scholarly journals The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL Consortium

2011 ◽  
Vol 47 (9) ◽  
pp. 1373-1379 ◽  
Author(s):  
Lynda M. Vrooman ◽  
Donna S. Neuberg ◽  
Kristen E. Stevenson ◽  
Barbara L. Asselin ◽  
Uma H. Athale ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukaemia ◽  
Children And Adolescents ◽  
Lymphoblastic Leukaemia ◽  
Acute Myelogenous Leukaemia ◽  
Myelogenous Leukaemia ◽  
Dana Farber Cancer Institute ◽  
Acute Myelogenous ◽  
Low Incidence

Correlation of Bone Marrow Morphology and Immunophenotyping in Acute Leukaemia Patients

2020 ◽  
Vol 4 (02) ◽  
pp. 30-32
Author(s):  
Muhammad Nurul Farhad ◽  
Salma Afrose ◽  
Md. Sirajul Islam ◽  
Gazi Yeasinul Islam
Keyword(s):  
Bone Marrow ◽  
Acute Lymphoblastic Leukaemia ◽  
Lymphoblastic Leukaemia ◽  
Acute Leukaemia ◽  
Acute Myelogenous Leukaemia ◽  
Myelogenous Leukaemia ◽  
College Hospital ◽  
Bone Marrow Morphology ◽  
Acute Myelogenous ◽  
Bone Marrow Study

Background: Acute leukaemia (AL) is a malignant disorder of the blood that is characterized by blocked or impaired differentiation of haemopoietic stem cells, resulting in abnormal accumulation of immature precursors and suppression of growth and maturation of cells in vivo. Objective: To find out correlation between morphological and immunophenotypic study of bone marrow among acute leukaemia patient. Methods/Procedure: This is a comparative cross sectional  study of diagnosis of leukaemia by bone marrow study and immunophenotyping from bone marrow sample with bone marrow alone of suspected cases of leukaemia treated in the department of haematology in Dhaka Medical College Hospital (DMCH)from March 2013 to August 2013 .Bone marrow examination and immunophenotyping was done simultaneously but having bone marrow morphology report we have compared with flow report. Results: Out of 50 patients according to Bone marrow study (BMS) 25(50.0%) of the patients had acute myelogenous leukaemia, 24(48.0%) had acute lymphoblastic leukaemia and 1(2.0%) had acute leukaemia. On the other hand, in immunophenotyping 28(56.0%) patients had acute lymphoblastic leukaemia, 20(40.0%) had acute myelogenous leukaemia and 2(4.0%) mixed cell immunophenotyping. Discordance of diagnosis was found in 3(6%) is diagnose as AML which was ALL on flow and one acute leukaemia and one AML was subsequently diagnose as mixed cellular leukaemia. Conclusion: Subjective variation in the accuracy of diagnosis of leukaemia on the basis of bone marrow study alone may occur. Inclusion of immunophenotyping with bone marrow study improves accuracy of leukaemia.

Acute myelogenous leukaemia in older patients at St Bartholomew's Hospital: outcome with mitoxantrone and cytarabine

2002 ◽  
Vol 3 (5) ◽  
pp. 237-243 ◽  
Author(s):  
Christopher D Dalley ◽  
Deborah L Lillington ◽  
Michael Bradburn ◽  
Maxine Carter ◽  
John A Amess ◽  
...  
Keyword(s):  
Older Patients ◽  
Acute Myelogenous Leukaemia ◽  
Myelogenous Leukaemia ◽  
Hospital Outcome ◽  
Acute Myelogenous

LONG-TERM REMISSION IN ACUTE MYELOGENOUS LEUKAEMIA

The Lancet ◽  
1984 ◽  
Vol 323 (8376) ◽  
pp. 571 ◽  
Author(s):  
T. Büchner ◽  
D. Urbanitz ◽  
B. Emmerich ◽  
J. Fischer ◽  
A. Heinecke ◽  
...  
Keyword(s):  
Acute Myelogenous Leukaemia ◽  
Myelogenous Leukaemia ◽  
Acute Myelogenous

Acute myelogenous leukaemia in a mare

1997 ◽  
Vol 75 (5) ◽  
pp. 329-331 ◽  
Author(s):  
NC RINGGER ◽  
L. EDENS ◽  
P. BAIN ◽  
RE RASKIN ◽  
R. LAROCK
Keyword(s):  
Acute Myelogenous Leukaemia ◽  
Myelogenous Leukaemia ◽  
Acute Myelogenous

A randomized study of intermediate versus conventional-dose cytarabine as intensive induction for acute myelogenous leukaemia

1992 ◽  
Vol 81 (2) ◽  
pp. 170-177 ◽  
Author(s):  
Gary Schiller ◽  
James Gajewski ◽  
Stephen Nimer ◽  
Mary Territo ◽  
Winston Ho ◽  
...  
Keyword(s):  
Acute Myelogenous Leukaemia ◽  
Randomized Study ◽  
Myelogenous Leukaemia ◽  
Conventional Dose ◽  
Acute Myelogenous
Sign in / Sign up

Export Citation Format

Share Document